Oriflame

Thesis

Oriflame, a cosmetics manufacturer, is currently undervalued as its share price has not increased since its IPO in 2006, despite growth in sales and profits. The company faces challenges due to its exposure to the Russian market and currency mismatches, but its long-term operating history suggests potential for recovery and value appreciation.

Did it work?

Not yet analyzed

No outcome has been scored for this pitch yet, so there's no verdict to show.